Regulatory Affairs Services Provider in Cambodia
DDReg provides regulatory affairs services in Cambodia for pharmaceutical, medical device, traditional medicine, and health supplement companies. Our consultants manage DDF registration services Cambodia through the CamPORS digital portal, coordinate subcommittee evaluation processes, and maintain post-registration compliance for products across Cambodia's growing import-dependent healthcare market.
Cambodia's Regulatory Framework for Medicines and Medical Devices
The Ministry of Health (MoH) holds overall authority for pharmaceutical regulation in Cambodia. The Department of Drugs and Food (DDF) operates under the MoH and serves as the operational regulatory body responsible for the quality, safety, and efficacy assessment of medicines, medical devices, cosmetics, health supplements, traditional medicines, and food products. Within the DDF, the Registration and Cosmetics Bureau administers all product registration activities it receives applications, screens dossiers, coordinates committee review, and issues registration certificates.
The primary legislation is the Law on the Management of Pharmaceuticals and its amendment law, supplemented by a series of Prakas (ministerial proclamations) for specific product categories. Cambodia's pharmaceutical market is predominantly import-dependent, with the DDF accepting foreign registration documentation and international laboratory data in recognition of the country's developing laboratory infrastructure. DDF regulators explicitly acknowledge reliance on foreign regulatory assessments from reference markets when evaluating dossiers for innovative and new molecules.
Cambodia participates in ASEAN regulatory harmonisation frameworks. Pharmaceutical dossiers follow the ASEAN Common Technical Document (ACTD) format distinct from the ICH CTD used in EU and US markets. Medical devices are regulated under Prakas No. 1258 (8 November 2012) and align with the ASEAN Medical Device Directive (AMDD), which establishes harmonised standards across ASEAN member states. The CamPORS digital registration portal, launched 1 August 2019 with WHO support, serves as the primary submission platform for all product categories.
Regulatory Drug Authorities in Cambodia
| Authority / Body | Role |
|---|---|
| MoH (Ministry of Health) | Overall regulatory authority; issues pharmaceutical establishment licences; sets health policy and pharmaceutical legislation |
| DDF (Department of Drugs and Food) | Operational regulatory body; administers CamPORS portal; manages dossier screening, subcommittee/committee review, and registration certificate issuance |
| Registration and Cosmetics Bureau (within DDF) | Bureau responsible for all product registration activities: application intake, pre-screening, committee scheduling, certificate issuance |
| Ministry of Commerce (MoC) | Issues Certificate of Incorporation required for local representative companies; separate from MoH pharmaceutical licensing |
Regulatory Consulting in Cambodia - Services Portfolio
DDReg's regulatory services in Cambodia cover all DDF-regulated product categories across initial registration, variations, renewals, and post-market compliance.
-
Pharmaceutical Drug Registration
-
Medical Device Registration
-
Regulatory Strategy and Market Intelligence
DDF Registration Services Cambodia - Submission Process
DDReg manages Cambodia regulatory submissions through structured phases:
-
Pre-Submission Preparation
-
Dossier Preparation
-
CamPORS Submission and Pre-Screening
-
Subcommittee and Committee Evaluation
-
Registration Certificate and Market Access
Cambodia Regulatory Approval Timelines
DDF publishes no statutory assessment timelines. Actual timelines depend on dossier completeness, DDF committee scheduling, and the frequency of additional information requests:
| Product / Procedure | Typical Timeline |
|---|---|
| New pharmaceutical (innovative) | 12–24 months from accepted submission |
| Generic pharmaceutical | 6–12 months |
| Health supplement / health supporting product | 3–9 months |
| Traditional medicine | 6–12 months |
| Cosmetics | 3–6 months |
| Medical device (Class A–B) | 6–12 months (committee cycle dependency) |
| Medical device (Class C–D) | 12–18 months |
| Medical device renewal (3-year cycle) | 3–6 months from complete application |
| Variation (minor) | 2–4 months |
| Variation (major) | 4–9 months |
Note: DDF medical device committees convene every 3–4 months. Applications not resolved at a scheduled committee meeting roll to the next cycle, adding 3–4 months to the total timeline. DDReg times submissions to align with committee cycles and prepares complete dossiers to prevent pre-screening rejection.
Cambodia Regulatory Affairs Partner - DDReg's Expertise
Cambodia follows the ASEAN Common Technical Document (ACTD) format, a four-part structure distinct from the five-module ICH CTD used in EU and US submissions. DDReg prepares ACTD-format dossiers from source CTD data, adapting administrative documentation for DDF requirements, restructuring non-clinical and clinical summaries to ACTD Part III and IV conventions, and confirming pharmacopoeial references match DDF-accepted compendial standards.
CamPORS requires credential registration with in-person document verification by DDF officers before portal access is granted. DDReg coordinates this setup for local representatives, manages all CamPORS digital submissions, and tracks application status through pre-screening and committee evaluation stages. For medical devices, DDReg manages the parallel hard-copy submission requirements alongside the digital portal workflow.
DDF requires all registration applications to be submitted by a pharmacist or a licensed pharmaceutical company registered with MoH. For medical devices, the local applicant must additionally hold a MoC Certificate of Incorporation and employ a registered pharmacist. DDReg coordinates local representative identification, ensures all prerequisite licences are in order before submission, and manages DDF communications through the local representative throughout the evaluation process.
DDF explicitly accepts foreign registration documentation and reference market data in recognition of Cambodia's laboratory infrastructure constraints. DDReg structures each dossier to leverage available FDA, EMA, TGA, or WHO prequalification assessments as supporting clinical and safety evidence, reducing the documentation gap for products without Cambodia-specific trial data and accelerating DDF evaluation.
DDF medical device committee meetings convene every three to four months. Applications that arrive at the committee incomplete or with outstanding queries roll to the next cycle, adding a full quarter to the approval timeline. DDReg tracks committee scheduling, submits complete dossiers timed to precede committee dates, and resolves additional information requests before the next committee cycle to prevent avoidable rollover delays.
Global Reach Explorer
Find Your Solution
Our Regulatory Affairs Consulting Services in Cambodia portfolio covers:
Regulatory Strategies
The pharmaceutical industry operates under stringent regulations to ensure the safety, efficacy, and quality...
New Product Marketing Authorizations
Navigating marketing authorization is a complex and time-sensitive process. Every country has its own regulatory framework...
Gap Analysis and Remediation
In the highly regulated pharmaceutical industry, maintaining compliance is critical. Regulatory gap analysis helps identify deficiencies in technical documentation...
Regulatory Due Diligence
Regulatory issues arise unexpectedly and can create significant strain on a company’s resources. As such, it is advisable for all companies to carry out regular and frequent regulatory due diligence and audits...
API & DMF services
Drug Master Files (DMFs) contain confidential and detailed information regarding API processes—from manufacturing to storage. DDReg’s DMF Services deliver precise...
CMC Advisory
DDReg’s CMC services are dedicated to assisting customers in developing robust and an efficient regulatory strategy through all development phases - authoring...
Post Approval Life Cycle Management
Maximize product value with expert pharma lifecycle management. Our dedicated team ensures that your product remains on shelves and compliant with ever-evolving regulations through strategic post-approval management...
Certification Services
Partner with DDReg to navigate the complex process of regulatory certification of pharmaceutical...
ANDA and MA Holder Services
Our comprehensive services support both Abbreviated New Drug Applications (ANDA) and Marketing Authorization processes.
Publishing & Submission
Our comprehensive digital solution transforms traditional paper dossier submissions into a streamlined electronic format. With robust infrastructure and cutting‐edge management processes...
